North American Commercial Expansion
Rovensa Next to Distribute Novonesis’ Biosolutions for Plant Health in the United States
Landmark Commercial Agreement Integrates Core Microbial Inoculants and Biostimulants for the 2027 Crop Cycle
In a major consolidation of commercial biological networks, Rovensa Next to Distribute Novonesis’ Biosolutions for Plant Health in the United States. Finalized on June 11, 2026, the comprehensive distribution agreement positions Rovensa Next to assume direct commercial responsibilities for select Novonesis agricultural portfolios starting in the 2027 growing season. The strategic alliance targets a North American biologicals market projected to reach $5.5 billion by 2027, integrating flagship soybean, broadacre, and specialty offerings—including Optimize®, NodPro®, Cell-Tech®, and Actinovate®—into Rovensa Next’s unified commercial footprint. While Novonesis retains select forage segments, the collaborative model establishes a full-cycle, seed-to-shelf biosolutions matrix backed by the combined strength of regional distribution networks.
FRANKLINTON, NC – June 11, 2026 — Novonesis and Rovensa Next today announced a distribution agreement under which Rovensa Next will commercialize select Novonesis agricultural biosolutions in the United States, beginning with the 2027 growing season. Through this agreement, Rovensa Next will deliver a more complete suite of biosolutions–from seed treatment through post-harvest–bringing together biostimulants, biofertilizers, bionutrition, biocontrol, and adjuvants to growers.
North America is one of the fastest-growing and most dynamic markets for agricultural biologicals, projected to reach approximately $5.5 billion by 2027, growing at more than 12% CAGR during the forecast period (2023–2027), as growers increasingly seek more targeted, science-based alternatives that deliver measurable value in the field while supporting sustainability goals.
Growers have relied on Novonesis for 130 years of proven innovative biosolutions. Under this agreement, Novonesis will continue to manufacture high-quality products, supporting the availability of solutions designed to improve productivity and performance for U.S. growers.
“This partnership with Rovensa Next aligns with our ambition to put more solutions into the hands of retailers and growers,” said René Garza, Senior Vice President of Planetary Health, Novonesis. “We’re especially excited about accelerating momentum in soybeans with core products like Optimize®, NodPro® and Cell-Tech® XC with its new ProPort Technology, and in pulses where TagTeam® BioniQ® and Cell-Tech® Multi-Pulse have already delivered strong double-digit growth.”
Rovensa Next, as a pure-play biosolutions ag-input company, has significantly strengthened its presence in the United States in recent years through the integration of leading companies such as Oro Agri, Agro-K, and Cosmocel. Today, the company operates with strong access to both specialty crop regions and broad-acre markets, supported by a well-established network of regional and national distributors. The United States is now Rovensa Next’s third largest market by revenue, underscoring its strategic importance.
“Growers want solutions that are easy to use, proven to work, and deliver an ROI they can count on,” said Chuck Broughton, Head of North America at Rovensa Next. “The portfolio from this partnership, combined with the existing Rovensa Next portfolio, is built to deliver exactly that–and it happens to be grounded in biosolutions that solve critical crop production problems.”
Under the agreement, Rovensa Next will assume direct commercial responsibilities for products focused on soybeans, corn, pulses, and peanuts, including Optimize®, NodPro®, Torque®, Ratchet®, BioniQ®, TagTeam®, QuickRoots®, Cell-Tech® and JumpStart®. For fruit and vegetable crops, Actinovate® will be distributed by Rovensa Next alongside their biocontrol portfolio. Novonesis will retain select segments, including the forage portfolio of Optimize® and Nitragin® products for alfalfa and clover crops.
About Novonesis
Novonesis is a global company leading the era of biosolutions. By leveraging the power of microbiology with science, we transform the way the world produces, consumes and lives. In more than 30 industries, our biosolutions are already creating value for millions of consumers and benefitting the planet. Our 10,000 people worldwide work closely with our partners and customers to transform business with biology.
About Rovensa Next
Rovensa Next is the global leader in biosolutions for agriculture. With over 2,200 employees spread around the world, Rovensa Next markets its products in over 90 countries. It brings together a global network of 39 R&D laboratories, excellence centers, fields and greenhouses, 12 production plants, and a dedicated team of more than 850 field experts. The company builds on innovative technologies and farming practices, supporting distribution partners and growers with holistic solutions to increase profitability, boost yields and maximize performance.
Strategic Market Context
The strategic commercial alliance between an established manufacturing giant and a consolidated pure-play distribution powerhouse reflects a structural shift toward integrated, multi-tiered partnerships in the biologicals arena. As broadacre and specialty growers demand audited return-on-investment metrics to supplement conventional inputs, input providers are building robust cross-portfolio supply channels. This commercial alignment corresponds with key strategic rollouts across the global bio-input sector, such as BTU and BINFIELD executing full industrial manufacturing of FERTIS ACTIVE NPK to coat mineral granules with protective spore cultures, and Bayer partnering with Aphea.Bio to advance non-living microbial metabolite bioinsecticides through coordinated global distribution channels.
Novonesis & Rovensa Next Commercial Alliance
Franklinton, NC & Madrid, Spain | North American Supply Registry | June 2026 | rovensanext-na.com
Leave a Reply